Endo International PLC
NASDAQ:ENDP
Endo International PLC
Revenue
Endo International PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Endo International PLC
NASDAQ:ENDP
|
Revenue
$2.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Revenue
$4.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Revenue
$3.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Revenue
$28m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
21%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Revenue
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Revenue
€96.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Endo International PLC's Revenue?
Revenue
2.3B
USD
Based on the financial report for Dec 31, 2022, Endo International PLC's Revenue amounts to 2.3B USD.
What is Endo International PLC's Revenue growth rate?
Revenue CAGR 1Y
-23%
Over the last year, the Revenue growth was -23%.